Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Other Operating Expense : ¥704 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Other Operating Expense?

Jiangsu Hengrui Pharmaceuticals Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥3 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥704 Mil.

Jiangsu Hengrui Pharmaceuticals Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-454 Mil) to Dec. 2023 (¥809 Mil) but then declined from Dec. 2023 (¥809 Mil) to Mar. 2024 (¥3 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual Other Operating Expense declined from Dec. 2021 (¥698 Mil) to Dec. 2022 (¥459 Mil) but then increased from Dec. 2022 (¥459 Mil) to Dec. 2023 (¥727 Mil).

Jiangsu Hengrui Pharmaceuticals Co Other Operating Expense Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Other Operating Expense Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

717.72

888.69

697.90

458.68

726.91

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															26.40	345.73	-454.46	809.25	3.34

Jiangsu Hengrui Pharmaceuticals Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥704 Mil.

Jiangsu Hengrui Pharmaceuticals Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines